| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 8 |
| 1 | CARBOPLATIN | 3 |
| 2 | DUPILUMAB | 3 |
| 3 | DURVALUMAB | 3 |
| 4 | PACLITAXEL | 3 |
| 5 | RITUXIMAB | 3 |
| 6 | AZACITIDINE | 2 |
| 7 | ETELCALCETIDE | 2 |
| 8 | ORAL SEMAGLUTIDE | 2 |
| 9 | RIOCIGUAT | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SETMELANOTIDE | 1 | 0.0035 |
| 1 | ETELCALCETIDE | 2 | 0.0007 |
| 2 | TREMELIMUMAB | 2 | 0.0005 |
| 3 | COLESTIPOL HYDROCHLORIDE | 1 | 0.0004 |
| 4 | LEMBOREXANT | 1 | 0.0003 |
| 5 | DEUCRAVACITINIB | 1 | 0.0003 |
| 6 | DURVALUMAB | 3 | 0.0001 |
| 7 | FINASTERIDE | 8 | 0.0001 |
| 8 | PERAMPANEL | 1 | 0.0001 |
| 9 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |
| 3 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | 5-alpha Reductase Inhibitor [EPC] | 8 | 0.0001 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 6 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 2 | 0.0001 |
| 9 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |